loading

Tscan Therapeutics Inc Azioni (TCRX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
2.23%
2.567
2.511 3.076 2.171 0.665
Operating Expenses
33.21%
26.43
39.56 41.73 38.42 37.38
Interest Income/Expense
0.43%
0.702
0.699 0.689 0.679 0.784
Benefits Costs and Expenses
25.54
- - 36.30 36.47
Costs And Expenses
35.43%
25.54
39.56 41.73 36.30 36.47
Operating Income/Loss
35.61%
-23.86
-37.05 -38.65 -36.25 -36.71
Income/Loss From Continuing Operations Before Tax
1,015%
-22.98
2.511 3.076 -34.13 -35.81
Income/Loss From Continuing Operations After Tax
35.66%
-22.98
-35.71 -36.95 -34.13 -35.81
Net Income/Loss
35.66%
-22.98
-35.71 -36.95 -34.13 -35.81
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.98%
0.0285
129.84 129.73 129.68 2.9545
Diluted Average Shares
99.98%
0.0285
129.84 129.73 129.68 2.9545
Basic Earnings Per Share
35.71%
-0.18
-0.28 -0.28 -0.26 -0.30
Diluted Earnings Per Share
35.71%
-0.18
-0.28 -0.28 -0.26 -0.30
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):